Law firm Stephenson Harwood LLP has advised BlueGem Capital Partners on a liquidity offering made to all investors in BlueGem L.P., a 2007 vintage private equity fund.
The transaction involved BlueGem L.P.'s four portfolio companies being transferred to BlueGem Secondary LP, a new fund managed by BlueGem and backed by Glendower Capital, a spin-out of Deutsche Bank's secondaries private equity business.
Sidley advised Pentamaster International Limited (SEHK:1665) (Pentamaster) on the company’s initial public offering on the Main Board of the Stock Exchange of Hong Kong Limited. The total offering amount was US$47.1 million.
Pentamaster is a leader in providing advanced, world-class manufacturing automation solutions and services to help customers worldwide to meet their productivity challenges and maintain the edge required for success in the ever-competitive business environment.
Sidley has advised A-Living Services Co. Ltd. (SEHK: 3319) (A-Living Services), the property management subsidiary of leading Chinese developer Agile Group Holdings Limited, in connection with its initial public offering (IPO) with the offer size of HK$4.1 billion (approximately US$525.5 million) on the Main Board of the Stock Exchange of Hong Kong Limited. Upon the IPO, the market capitalization of A-Living Services was over HK$16 billion.
With a team led by Frankfurt-based Partner Michael Schlitt Hogan Lovells has advised AKASOL AG on its IPO. AKASOL AG is a leading German manufacturer of high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, marine and stationary applications.
Charles Russell Speechlys advised Cake Box on its admission to AIM which completed on 27 June 2018.
Cake Box specialises in sponge cakes decorated with fresh cream. The egg-free nature of their recipes allows the company to target a larger potential market, including those whose allergies or religious requirements prevent them from eating most cakes. Since its launch in East London in 2008 the business has grown to have an estate of 91 stores and is currently targeting a further 250 franchise stores.
Transaction represents the second high-profile city commercial bank IPO on which the firm has advised this year
Latham & Watkins has advised CCBI and CLSA as joint sponsors and underwriters of Jiangxi Bank Co., Ltd.’s HK$7.48 billion initial public offering on the Main Board of The Stock Exchange of Hong Kong. The offering consists of 1.17 billion H Shares sold at an offer price of HK$6.39 per Share.
Global law firm White & Case LLP has advised Projektengagemang Sweden AB and its principal owners on the SEK 1.2 billion (approximately €116.5 million) initial public offering and listing of Projektengagemang on Nasdaq Stockholm.
Projektengagemang is a multi-disciplinary operator in the Swedish technical consulting market, offering services in areas such as architecture, project management, urban planning, building design, infrastructure, industry and energy to customers in both the private and public sectors.
Lalique Group SA completed its listing on SIX Swiss Exchange (ticker symbol: LLQ / ISIN CH0033813293). Together with the switch of the listing from BX Swiss to the SIX Swiss Exchange, the company issued 1,000,000 new shares in a rights offering. The opening price of the shares was CHF 51, which leads to a market capitalization of Lalique Group SA of CHF 306 million.
Hong Kong – Paul Hastings, a leading global law firm, announced today that the firm advised Jiangxi Bank on its US$952 million global offering and listing of its H shares on the Hong Kong Stock Exchange. CCB International Capital Limited, CLSA Limited, and AMTD Global Markets Limited acted as the joint global coordinators. Jiangxi Bank is the only provincial city commercial bank in Jiangxi Province, China.
Travers Smith LLP has acted for Numis Securities Limited, as nominated adviser and bookrunner, and Investec Bank plc, as bookrunner, in connection with the £34 million placing of new shares by Alliance Pharma plc ("Alliance") in connection with its acquisition from Janssen Pharmaceutica NV (a member of the Johnson & Johnson group of companies) of the exclusive marketing rights to Nizoral, a medical, anti-dandruff shampoo brand, in Asia-Pacific for total consideration of £60 million.